Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: A quantitative 31P-magnetic resonance spectroscopy and MRI study

Brain

Volumn 125, Issue 7, 2002, Pages 1635-1645

  Cea, Gabriel ^a,b,c   Bendahan, David ^a,d   Manners, David ^a   Hilton Jones, David ^b   Lodi, Raffaele ^a,e   Styles, Peter ^a   Taylor, Doris J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CHILE   (Chile)

^d University of Aix Marseille   (France)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

31P MRS; Dermatomyositis; Oxidative phosphorylation; Polymyositis; Quantitative MRI

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHORUS 31;

ADULT; AEROBIC METABOLISM; ARTICLE; CAPILLARY BLOOD; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; EXERCISE; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MITOCHONDRION; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; OXIDATION; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; PROTON TRANSPORT; SKELETAL MUSCLE; VASCULARIZATION;

EID: 0036314637     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awf163     Document Type: Article

References (54)

1. Muscular atrophy following immobilisation. A review
2. Bioenergetic heterogeneity of human mitochondrial myopathies: Phosphorus magnetic resonance spectroscopy study
3. 31P magnetic resonance spectroscopy study
4. 31P NMR
5. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy
6. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies
7. Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy
8. Respiratory chain enzyme defects in patients with idiopathic inflammatory myopathy
9. Distribution of capillaries in normal and diseased human skeletal muscle
10. Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies
11. Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure
12. Modeling in vivo recovery of intracellular pH in muscle to provide a novel index of proton handling: Application to the diagnosis of mitochondrial myopathy
13. Glycolysis is independent of oxygenation state in stimulated human skeletal muscle in vivo
14. Polymyositis, dermatomyositis and inclusion-body myositis
15. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle
16. Mitochondrial encephalomyopathies
17. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years
18. Microvascular changes in early and advanced dermatomyositis: A quantitative study
19. pHi measurements of cardiac and skeletal muscle using 31P-NMR
20. Adjustment of K' to varying pH and pMg for the creatine kinase, adenylate kinase and ATP hydrolysis equilibria permitting quantitative bioenergetic assessment
21. Measurement of magnetic resonance T2 for physiological experiments
22. Effect of acidosis on control of respiration in skeletal muscle
23. The signal transduction function for oxidative phosphorylation is at least second order in ADP
24. Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle
25. The production, buffering and efflux of protons in human skeletal muscle during exercise and recovery
26. Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise
27. Comparisons of ATP turnover in human muscle during ischemic and aerobic exercise using 31P magnetic resonance spectroscopy
28. Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy
29. Magnetic resonance spectroscopy studies of human muscle
30. Correlative MR imaging and 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy
31. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy
32. Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study
33. Histological and biochemical assessment of mitochondrial function in dermatomyositis
34. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis. Altered energy utilization during exercise
35. Mitochondrial DNA deletions in muscle fibers in inclusion body myositis
36. Dermatomyositis: Correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease
37. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis
38. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis
39. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies
40. Muscle imaging in inflammatory myopathies
41. Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults
42. Ragged red fibers in normal aging and inflammatory myopathy
43. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients
44. 31P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure
45. Control of the rate of phosphocreatine resynthesis after exercise in trained and untrained human quadriceps muscles
46. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease
47. Bioenergetics of skeletal muscle in mitochondrial myopathy
48. Skeletal muscle mitochondrial function studied by kinetic analysis of postexercise phosphocreatine resynthesis
49. Quantitative data analysis of in vivo MRS data sets
50. Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge
51. Longitudinal study of skeletal muscle adaptations during immobilization and rehabilitation
52. Water-fat imaging with direct phase encoding
53. Inhibition of brain macrophage/microglial respiratory chain enzyme activity in experimental autoimmune encephalomyelitis of the Lewis rat